Chip Diagnostics is commercializing an innovative hardware and data/AI informatics platform, used to develop novel, exosome-based biomarker signatures for early disease diagnostics and therapy management. We developed a proprietary workflow to rapidly scan blood samples for trillions of exosomes individually to identify and interpret organ-specific exosome populations. Our solutions enable extremely accurate “fingerprinting” of a broad range of diseases and their states, offering inexpensive, and less time and resource-intensive workflows across biopharma/drug discovery and diagnostics use cases.